secwatch.observer — SEC 8-K summary
======================================

Issuer:     TransMedics Group, Inc. (TMDX)
CIK:        0001756262
Form:       8-K
Filed at:   2026-02-04T23:59:59+00:00
Accession:  0001193125-26-037615
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

TransMedics appoints new CCO and new General Counsel in leadership transition
-----------------------------------------------------------------------------

- Giovanni Cecere appointed Chief Commercial Officer effective Feb 2, 2026, succeeding Tamer Khayal who becomes SVP International.
- Matthew Forsyth appointed SVP, General Counsel & Corporate Secretary effective March 9, 2026, succeeding Anil Ranganath.
- Anil Ranganath transitions to non-executive employee until June 7, 2026, then consultant through Sept 7, 2026; retains base salary and equity vesting.
- Ranganath eligible for severance of 0.75x highest salary+bonus, COBRA for 9 months, and pro-rated 2026 bonus subject to release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756262/000119312526037615/0001193125-26-037615-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756262/000119312526037615/d50302d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-037615

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer